In a recent study published in Science Immunology, researchers investigated the CAMCI (combination of cell activation and metabolic checkpoint inhibition) strategy as an immunotherapeutic option for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback